Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Stockholders Approve Merger

NEW YORK, June 27 - Stockholders have approved the merger of Bruker Daltonics and Bruker AXS, the two companies said today.


Both companies held shareholder meetings today, at which the majority of stockholders voted in favor of the merger.


The combined company will be called Bruker BioSciences and is expected to begin trading under its new name and Nasdaq symbol, BRKR, on July 2.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more